Intermountain Study Shows Weight Loss Drugs Dont Increase Risk of Pancreatitis or Adverse Cardiac Events in Patients with High Triglycerides In a major new study, researchers from Intermountain Health in Salt Lake City have found that weight loss drugs used by patients who have high triglycerides do not increase their risk of pancreatitis or adverse cardiac events
Wang, W., Pan, D., Liu, Q., Chen, X., & Wang, S
El Sahly says, noting that researchers are looking into it
Why there is no significant interaction The lack of interaction comes down to how each drug is processed
This includes Medicare, Medicaid, and all private plans
At AesthetiCare, we understand the challenges patients face in navigating these changes